We know this because mice with defects in Trp53 are highly tumor prone; in humans inherited TP53 mutations, Li-Fraumeni Syndrome, is characterized by multiple tumor types, and about half of all human cancers contain TP53 mutations (www.iarc.p53.fr) [reviewed in ref. 1]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.